Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$339,907
+$72,972 QoQ
Shares Held
3,990
-1.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#333
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. CYTK ranks #33 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,907 | 3,990 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $266,935 | 4,050 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $312,616 | 4,920 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $236,766 | 4,308 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $56,960 | 1,724 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $96,857 | 2,410 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $81,755 | 1,738 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $279,311 | 5,290 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $381,534 | 7,042 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $394,998 | 5,634 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $281,277 | 3,369 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $382,095 | 12,970 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $572,088 | 17,538 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $670,017 | 19,040 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $900,270 | 19,648 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $977,284 | 20,171 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $993,682 | 25,291 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $700,014 | 19,017 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $874,315 | 19,182 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $691,603 | 19,351 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $33,385 | 1,687 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $16,026 | 689 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $14,317 | 689 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $9,699 | 448 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $4,478 | 190 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $2,240 | 190 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||